---

英國醫學雜志（British Medical Journal，BMJ）是世界著名的四大綜合性醫學期刊之一

BMJ的副主編Peter Doshi質疑輝瑞和莫得納的新冠疫苗實驗數據造假，他的文章刊發在BMJ
的網站上：https://tinyurl.com/y62nggy4




Peter Doshi: Pfizer and Moderna’s “95% effective” vaccines—we need more
details and the raw data
Peter Doshi：輝瑞和莫得納疫苗的“95%有效”——我們需要更多細節和原始數據

……

“Suspected covid-19”
疑似新冠癥狀

All attention has focused on the dramatic efficacy results: Pfizer reported
170 PCR confirmed covid-19 cases, split 8 to 162 between vaccine and placebo
 groups. But these numbers were dwarfed by a category of disease called “su
spected covid-19”—those with symptomatic covid-19 that were not PCR confir
med. According to FDA’s report on Pfizer’s vaccine, there were “3410 tota
l cases of suspected, but unconfirmed covid-19 in the overall study populati
on, 1594 occurred in the vaccine group vs. 1816 in the placebo group.”
所有的注意力都集中在引人注目的療效結果上：輝瑞公司報告了170例經PCR證實的新冠
病例，分別是疫苗組8例和安慰劑組162例。但是這些數字與“疑似新冠”的癥狀相矛盾，
即那些有新冠癥狀、但未經PCR確診的疾病。根據FDA關于輝瑞疫苗的報告，在整個研究
人群中，共有3410例疑似但未確認的新冠病例，疫苗組有1594例，安慰劑組有1816例

With 20 times more suspected than confirmed cases, this category of disease
cannot be ignored simply because there was no positive PCR test result. Inde
ed this makes it all the more urgent to understand. A rough estimate of vacc
ine efficacy against developing covid-19 symptoms, with or without a positiv
e PCR test result, would be a relative risk reduction of 19% (see footnote)—
far below the 50% effectiveness threshold for authorization set by regulator
s. Even after removing cases occurring within 7 days of vaccination (409 on
Pfizer’s vaccine vs. 287 on placebo), which should include the majority of
symptoms due to short-term vaccine reactogenicity, vaccine efficacy remains
low: 29% (see footnote).


--
--
※ 發信站: 批踢踢實業坊(ptt.cc), 來自: 183.160.55.73 (中國)
※ 文章代碼(AID): #1V_53JLe (Gossiping)
※ 文章網址: https://www.ptt.cc/bbs/Gossiping/M.1610371283.A.568.html